Article Information
History
- February 18, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Georgina Ireland1,*,
- Heather Whitaker2,*,
- Shamez N Ladhani1,5,
- Frances Baawuah1,3,
- Sathyvani Subbarao1,
- Suzanne Elgohari1,
- Alexandra Smith1,
- Michelle O’Brien3,
- Corinne Whillock1,
- Oliver Martin1,
- Paul Moss4,
- Mary E Ramsay1,
- Gayatri Amirthalingam1,** and
- Kevin E Brown1,**,†
- 1Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom
- 2Statistics, Modelling and Economics Department, UK Health Security Agency, London, United Kingdom
- 3Brondesbury Medical Centre, Kilburn, London, United Kingdom
- 4Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, United Kingdom
- 5Paediatric Infectious Diseases Research Group, St. George’s University of London, London, United Kingdom
- ↵†Correspondence: Kevin E Brown (kevin.brown{at}phe.gov.uk)